A Phase 2b Diabetic Kidney Disease Study

NCT04170543 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

609

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: MEDI3506
DRUG: Placebo
DRUG: Dapagliflozin

Sponsor

AstraZeneca